While medications like Wegovy and Mounjaro have become household names, a new treatment is on the horizon that might offer even more significant results
Eastern Time), you can continue Sunday injections at a convenient local time, or shift to another day of the week following your medications minimum spacing requirements
If those first two sound familiar, it's because the current generation of weight loss medications already targets them
In this dataset of GLP-1 discussions, people describe how they feel, what they try, and how they manage side effects
CagriSema requires managing two separate compounds, two reconstitutions, and potentially two injection sites per week
Key Takeaways: GLP-1 vs GIP Both are incretin hormones released by your intestines after eating GLP-1 primarily affects appetite, gastric emptying, and insulin secretion GIP influences insulin secretion, glucagon regulation, and fat metabolism Single GLP-1 agonists (semaglutide) produce 14.9% average weight loss Dual GLP-1/GIP agonists (tirzepatide) produce 22.5% average weight loss The dual action appears to create additive rather than merely overlapping effects Both receptor types play important roles in metabolic regulation Understanding the difference helps explain why tirzepatide shows superior results What Are Incretin Hormones
